News Archive

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs of the National Institutes of Health (NIH) supported the development of 99 drugs from 1996-2020 — a total that includes 16 percent of all such treatments that made a “significant” advance over available medicines. This finding is just one of the impacts that the National Academies of Sciences, Engineering and Medicine (NASEM) attributes to the program in a new report.

The Ellume COVID-19 Home Test is an over-the-counter, rapid self-test which detects SARS-CoV-2 antigen. The test is suitable for ages 2 years and above for over-the-counter home use in the U.S*. Clinically proven for use for people with and without symptoms, with accurate test results in 15 minutes.

Image: https://www.ellumehealth.com

While COVID has most certainly been top-of-mind for companies working to combat infectious disease, we must not forget the other microbes out there that are still cause for concern. 

Tuberculosis (TB) is a prime example. Most have heard of this disease, but probably in the context of their history classes. You might be surprised to hear, then, that tuberculosis caused an estimated 1.5 million deaths in 2020, making it second only to COVID as the leading cause of death due to an infectious agent.

Image: https://biobuzz.io

BROOKLYN, NY—New York City Economic Development Corporation (NYCEDC) announced a $50 million investment in life sciences at BioBAT to expand their lab space as part of the city’s LifeSci NYC initiative. NYCEDC and BioBAT officials toured the space that will receive funding to build new labs at BioBAT located at the Brooklyn Army Terminal.

Image: Photo courtesy of NYCEDC/Tory Williams

Maryland’s life sciences ecosystem has become a key hub along the eastern shore of the United States due to its position in infectious disease research and vaccine development and manufacturing. While the state saw an infusion of billions of dollars in government financing in the development of vaccines, Maryland’s Biotechnology Investment Incentive Tax Credit, is a tool that has been used to attract venture capital funding in the state.

The tax credit was established in 2005 to incentivize venture capital investment into the state of Maryland. Since 2016, the most recent year for full data, the state has offered more than $70 million in tax credits to 114 different entities. That, in turn, has generated about $140 million in investments into the state’s life sciences ecosystem, the Baltimore Business Journal reported. 

New zoning measure spearheaded by Friedson will accelerate and streamline the regulatory process to develop and spur expansion of biohealth facilities in Montgomery County

On Wednesday, February 16 at 10:30 a.m. Councilmember Andrew Friedson and Montgomery County biohealth and economic development leaders will hold a press conference to reinforce Montgomery County’s commitment to innovation and the biohealth sector at United Therapeutics Corp. in Silver Spring.

Ron Piervincenzi, Ph.D., CEO of United States Pharmacopeia, sits down with host, Rich Bendis, to discuss USP’s growth since his last visit, the nature of their organization, and plans on hosting the 2022 BioHealth Capital Region Forum in person at their beautiful building in Rockville, Maryland.

Listen now via Apple https://apple.co/3JpVTHB, Google https://bit.ly/3JnJfsI, Spotify https://spoti.fi/3JoLig7, and TuneIn https://bit.ly/3BhNcfE.

The University of Maryland Baltimore County has joined the highest ranks of research universities in the country, a milestone for the young school with a reputation for producing scientists and engineers of color.

The 55-year-old university in suburban Baltimore reached Research 1, or R1, status, a distinction for universities with very high research activity.

Image: Trevor Shepard, a chemistry major, works on a viscosity experiment at the University of Maryland Baltimore County in October 2020. (Michael Robinson Chavez/The Washington Post)

Rising to the Top: The Importance of Increasing Diversity in STEM Leadership

Join Young Women In Bio and Winward Academy for a special career panel to learn from the passionate journeys of incredible female leaders in successful science careers.

We’ll celebrate the International Day of Women in Science with Dr. Leticia Ferri and Ms. Wendy Clemens of Bristol Myers Squibb, the global pharmaceutical company, and with Ms. Abigail Hata of Horizon Therapeutics.

We’ll learn more about their personal journeys and tips for teens interested in science and STEM careers.

Small businesses with NHGRI grants were instrumental in contributing to the completion of the human genome sequence, redefining the future of genomics.

When Kelvin Liu began his doctorate degree in biomedical engineering at Johns Hopkins University in 2004, he knew his resume was unusual. His previous work painted him as more of an inventor and entrepreneur than an academic. Even before starting his doctoral research, Liu already had two patents under his name. Now, he has eight. Less than two years after graduating with his Ph.D., he became CEO of Circulomics, a biotechnology startup in downtown Baltimore. 

Image: https://www.genome.gov/news/news-release/NIH-funded-startups-are-fueling-the-era-of-genome-completeness